IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Beili Zhang

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 4.8

ph-index = 20

Forward Citations = 1,203(Granted Patents)


Company Filing History:

goldMedal32 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents

Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):
1. 12319693 - Crystalline forms of CFTR modulators (2025-06-03),
2. 12065432 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2024-08-20),
3. 11873300 - Crystalline forms of CFTR modulators (2024-01-16),
4. 11773119 - Prodrugs of pyridone amides useful as modulators of sodium channels (2023-10-03),
5. 11578062 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2023-02-14),
6. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2021-11-30),
7. 11155533 - Crystalline forms and compositions of CFTR modulators (2021-10-26),
8. 10906891 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2021-02-02),
9. 10787472 - Prodrugs of pyridone amides useful as modulators of sodium channels (2020-09-29),
10. 10654829 - Crystalline forms and compositions of CFTR modulators (2020-05-19),
11. 10597384 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2020-03-24),
12. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2020-02-25),
13. 10253054 - Prodrugs of pyridone amides useful as modulators of sodium channels (2019-04-09),
14. 10081621 - Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2018-09-25),
15. 9840499 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2017-12-12),

Title: Beili Zhang: Innovator in Pharmaceutical Science

Introduction

Beili Zhang is a prolific inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceutical science. With an impressive portfolio of 31 patents, Zhang has made remarkable strides in developing innovative treatments that enhance the quality of life for patients with various medical conditions.

Latest Patents

Zhang's latest patents reflect his expertise and innovative spirit. One of his notable inventions is a solid form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid. This invention involves a substantially crystalline and free solid-state form (Form I) which, along with its pharmaceutical compositions, offers potential methods of treatment. Additionally, his work on crystalline forms of CFTR modulators introduces new pharmaceutical compositions along with methods to treat cystic fibrosis, showcasing his dedication to addressing complex health challenges.

Career Highlights

Throughout his career, Beili Zhang has been associated with renowned companies, including Vertex Pharmaceuticals. His innovative research and patented technologies have contributed to the advancement of pharmaceutical therapeutics. Through his work, he has significantly impacted the landscape of drug development, paving the way for novel treatments.

Collaborations

Zhang has collaborated with several notable professionals in the industry, including Ali Keshavarz-Shokri and Mariusz Krawiec. These collaborations have fostered a rich environment for innovation and have led to the successful development of groundbreaking pharmaceutical applications.

Conclusion

Beili Zhang stands out as a leader in pharmaceutical innovation. His extensive patent portfolio and commitment to research highlight his role in advancing medical science, particularly in the development of treatments for serious health conditions. As he continues to innovate, Zhang's contributions to the field will undoubtedly continue to benefit patients and the medical community alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…